Marker Therapeutics, Inc. (MRKR:NASDAQ) closed at $0.930 on October 14, 2026, up 0.54% on the day. The stock trades 62.2% below its 52-week high of $2.46 and 10.7% above its 52-week low of $0.840. Over the past year, it lost 12.7%. Marker Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -4.65% | -20.95% | -30.98% | -44.28% | -12.75% |
In 252 trading sessions since October 13, 2025, MRKR closed higher on 109 days (43%). Its best day was April 9, 2026 (+19.86%) and its worst was January 26, 2026 (-10.95%). The stock moved 10% or more in a single session 15 times.
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Find more stocks like MRKR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.